Europium labeled lactosylated albumin as a model workflow for the development of biotherapeutics.
Bioconjugates development
Lanthanide chelates
Nanomedicines
Targeted imaging
Time resolved fluorescence
Journal
Nanomedicine : nanotechnology, biology, and medicine
ISSN: 1549-9642
Titre abrégé: Nanomedicine
Pays: United States
ID NLM: 101233142
Informations de publication
Date de publication:
06 2019
06 2019
Historique:
received:
16
10
2018
revised:
12
02
2019
accepted:
12
02
2019
pubmed:
8
3
2019
medline:
4
12
2019
entrez:
8
3
2019
Statut:
ppublish
Résumé
Lactosylated albumin is currently used as a radiopharmaceutical agent to image the liver asialoglycoprotein receptors and quantify hepatic liver function in various diseases. A lactosylated protein (LACTAL) conjugate showed excellent liver uptake compared to non-lactosylated protein and a high signal to noise ratio, based on the biodistribution in mice using
Identifiants
pubmed: 30844577
pii: S1549-9634(19)30042-5
doi: 10.1016/j.nano.2019.02.011
pii:
doi:
Substances chimiques
Agglutinins
0
Europium
444W947O8O
Ricin
9009-86-3
Lactose
J2B2A4N98G
Serum Albumin, Human
ZIF514RVZR
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
21-30Informations de copyright
Copyright © 2019 Elsevier Inc. All rights reserved.